Source: Annual Congress 2013 –PG2 Imaging in the management of thoracic malignancies
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. De Langen (Amsterdam, Netherlands). Imaging in the evaluation of tumour response of thoracic malignancies. Annual Congress 2013 –PG2 Imaging in the management of thoracic malignancies

Member's Comments

No comment yet.

Related content which might interest you: Imaging techniques for diagnosis and staging of thoracic malignancies Source: Annual Congress 2013 –PG2 Imaging in the management of thoracic malignancies Year: 2013 FDG-PET/CT for monitoring the response to treatment in thoracic and pancreatic sarcoidosis Source: Annual Congress 2009 - Old and new: technique and pathology Year: 2009 Imaging: staging of lung cancer Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-34-0, page=214 Year: 2004 NSCLC/SCLC diagnosis and staging of thoracic tumours Source: ERS Course 2018 - Summer school of adult respiratory medicine Year: 2018 NSCLC/SCLC diagnosis and staging of thoracic tumours Source: ERS Course 2019 - Summer school of adult respiratory medicine Year: 2019 NSCLC/SCLC diagnosis and staging of thoracic tumours Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017 NSCLC/SCLC diagnosis and staging of thoracic tumours Source: ERS Skills Course 2016 Year: 2016 Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma? Source: Eur Respir J 2011; 37: 162-168 Year: 2011 Tissue sampling techniques for diagnosis and staging of thoracic malignancies Source: Annual Congress 2013 –PG2 Imaging in the management of thoracic malignancies Year: 2013 Should all lung cancer patients requiring pathological nodal staging undergo PET-CT first? Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Should preoperative FDG uptake on PET/CT guide postoperative surveillance in surgical non-small cell lung cancer (NSCLC) Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Imaging features in post-operative lung cancer recurrence Source: International Congress 2018 – Imaging of various diseases with different imaging modalities Year: 2018 Synchronous primary malignancies identified during staging 18F-FDG PET scan in lung cancer patients Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 Combined endobronchial and esophageal endosonography for mediastinal staging in lung cancer: Systematic review and meta-analysis Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Preoperative FDG uptake on PET/CT predicts disease recurrence and survival in early stage non-small cell lung cancer (NSCLC) Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016 Comparative diagnostic accuracy of thoracic endosonography (EBUS/EUS-b) and integrated PET-CT in mediastinal staging of potentially operable patients with NSCLC. Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound Year: 2020 Attenuation change of lung nodules according to variation of examination techniques in low dose CT using iterative reconstruction: A phantom study Source: International Congress 2016 – Mixed-up imaging of various chest diseases Year: 2016 Is invasive staging necessary for NSCLC cases with no mediastinal N2 in PET/CT and thorax CT imaging? Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008 Diagnostic value of fiberoptic bronchoscopy in thoracic malignancies except primary lung tumor Source: Eur Respir J 2005; 26: Suppl. 49, 534s Year: 2005 Ultrasound guided true cut biopsy of peripheral lymph nodes as a staging procedure in patients with non-small cell lung cancer (NSCLC) Source: International Congress 2016 – EBUS and transthoracic ultrasound Year: 2016